Cite
HARVARD Citation
Mahlangu, J. et al. (2023). A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia. British journal of haematology. pp. 229-239. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mahlangu, J. et al. (2023). A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia. British journal of haematology. pp. 229-239. [Online].